Extracellular circulating miRNAs as potential non-invasive biomarkers in non-small cell lung cancer patients
Non-small cell lung cancer (NSCLC) comprises 85% of all lung cancers and is a malignant condition resistant to advanced-stage treatment. Despite the advancement in detection and treatment techniques, the disease is taking a deadly toll worldwide, being the leading cause of cancer death every year. C...
Main Authors: | Justyna Raczkowska, Agnieszka Bielska, Adam Krętowski, Magdalena Niemira |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1209299/full |
Similar Items
-
Recent Highlights of Research on miRNAs as Early Potential Biomarkers for Cardiovascular Complications of Type 2 Diabetes Mellitus
by: Agnieszka Bielska, et al.
Published: (2021-03-01) -
Serum miRNA Profile in Diabetic Patients With Ischemic Heart Disease as a Promising Non-Invasive Biomarker
by: Agnieszka Bielska, et al.
Published: (2022-05-01) -
Circulating miRNAs, Small but Promising Biomarkers for Autism Spectrum Disorder
by: Salam Salloum-Asfar, et al.
Published: (2019-10-01) -
Circulating miRNAs as a Predictive Biomarker of the Progression from Prediabetes to Diabetes: Outcomes of a 5-Year Prospective Observational Study
by: Iwona Sidorkiewicz, et al.
Published: (2020-07-01) -
Potential utility of miRNAs for liquid biopsy in breast cancer
by: Xiangrong Liu, et al.
Published: (2022-08-01)